Sculptor Capital’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Sculptor Capital’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-66,666	Closed	-$16.9K	–	843
2022 Q4	$16.9K	Hold	66,666	–	–	﹤0.01%	624
2022 Q3	$5K	Hold	66,666	–	–	﹤0.01%	1037
2022 Q2	$7K	Hold	66,666	–	–	﹤0.01%	1119
2022 Q1	$16K	Hold	66,666	–	–	﹤0.01%	1188
2021 Q4	$36K	Hold	66,666	–	–	﹤0.01%	1092
2021 Q3	$41K	Hold	66,666	–	–	﹤0.01%	930
2021 Q2	$66K	Buy	+66,666	New	+$62K	﹤0.01%	891

Sculptor Capital's EBACW Position: Q1 2023 in Review

Sculptor Capital sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 66,666 shares — an estimated $16.9K sold.

Sculptor Capital first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $66K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Sculptor Capital reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 66,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $16.9K.
Sculptor Capital first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Sculptor Capital's European Biotech Acquisition Corp. Warrant position peaked at $66K in Q2 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.